Please assess the completion status of the following clinical trial:

Trial Title: Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with advanced or metastatic renal cell carcinoma.~Exclusion Criteria:~* No previous cytokines therapy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients treated with SUTENT® (Type: None): Patients with metastatic or advanced renal cell carcinoma after failure of cytokines therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).